Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS reg reform

Executive Summary

HHS is asking the public to suggest federal health care regulations that "could be coordinated and simplified to reduce costs and burdens and improve the translation of biomedical research into medical practice," according to an Oct. 4 1Federal Register notice from the HHS Assistant Secretary for Planning & Evaluation. Responding to a congressional directive, HHS and the White House Office of Management & Budget will establish an interagency committee to examine major federal regulations that affect the health care industry and make suggestions for how they can be reformed. As part of the process, a series of public meetings will be held to gather comments from stakeholders, including patients, practitioners and health care administrators...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel